Covid-19 roundup: Con­tro­ver­sy around colchicine per­co­lates af­ter study fail­ure; As­traZeneca's meet­ing with EU was 'con­struc­tive,' but did­n't solve much

A group of re­searchers at the Mon­tre­al Heart In­sti­tute has spelled out what they had called pos­i­tive re­sults sug­gest­ing that colchicine, an in­ex­pen­sive oral an­ti …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER